The Patent Finder
US

Estimating Risk of Future Bone Fracture Utilizing Three-Dimensional Bone Density Model

US 9,153,021 Term ended
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Apr 8, 2026 (Royal Bank of Canada).

Term ended no later than Nov 10, 2026 · Medium confidence

Filed Jan 17, 2014 as application 14/158,261 · Granted Oct 6, 2015
Base term, 20 years from filing
Today
20 years from filing
Ended no later than Nov 10, 2026
2006 2026
Clock starts
Nov 10, 2006
Ended no later than
Nov 10, 2026
Granted
Oct 6, 2015
base term after the term ends fee events Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Nov 10, 2006, when application PCT/US2006/043730, the earliest non-provisional in its chain, was filed (this one was filed Jan 17, 2014)Nov 10, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderno later than Nov 10, 2026Medium confidence

This family

Application 60/735,741Provisional application
no patent term
no patent term
Application PCT/US2006/043730PCT application
no patent term
no patent term
US 8,634,629In force
Jun 2029
Jun 2029
US 9,153,021this patent
no later than Nov 2026
no later than Nov 2026
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 15, 2014
Reel 32676, frame 670
Wilson, KevinHologic, Inc.Assignment of Assignor's Interest
Apr 25, 2014
Reel 32753, frame 942
Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe IncorporatedGoldman Sachs Bank, USASecurity Interest
Jun 3, 2015
Reel 35813, frame 1
Goldman Sachs Bank USA, as Collateral AgentHologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe IncorporatedSecurity Interest Release Reel/Frame 032753/0942
Jun 3, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentHologic, Inc.Security Interest Release Reel/Frame 032753/0942
Jun 3, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentBiolucent, LLCSecurity Interest Release Reel/Frame 032753/0942
Jun 3, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentCytyc CorporationSecurity Interest Release Reel/Frame 032753/0942
Jun 3, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentCytyc Surgical Products, Limited PartnershipSecurity Interest Release Reel/Frame 032753/0942
Jun 3, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentDirect Radiography Corp.Security Interest Release Reel/Frame 032753/0942
Jun 3, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentSuros Surgical Systems, Inc.Security Interest Release Reel/Frame 032753/0942
Jun 3, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentThird Wave Technologies, Inc.Security Interest Release Reel/Frame 032753/0942
Jun 3, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentGen-Probe IncorporatedSecurity Interest Release Reel/Frame 032753/0942
Aug 7, 2015
Reel 36307, frame 199
Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.Bank of America, N.A., as Collateral AgentSecurity Agreement
Apr 8, 2026
Reel 75462, frame 440
Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc.Royal Bank of Canada, as Collateral AgentSecurity Interest
Apr 8, 2026
Reel 75926, frame 339
Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc.Citibank, N.A., as Collateral AgentSecurity Interest
Apr 28, 2026
Reel 75566, frame 39
Bank of America, N.A., as Collateral AgentHologic, Inc., on Its Own Behalf and as Successor-by-Merger to Direct Radiography Corp.; Cytyc Corporation, on Its Own Behalf and as Successor-by-Merger to Biolucent, LLC; Cytyc Surgical Products, LLC, as Successor-by-Conversion to Cytyc Surgical Products, Limited Partnership; Gen-Probe Incorporated, on Its Own Behalf and as Successor-by-Merger to Third Wave Technologies, Inc.; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited